Fidelity Investments’s Compugen CGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-150
Closed -$387 5397
2024
Q1
$387 Buy
+150
New +$349 ﹤0.01% 4865
2023
Q3
Sell
-176
Closed -$201 5303
2023
Q2
$201 Hold
176
﹤0.01% 4903
2023
Q1
$124 Hold
176
﹤0.01% 4883
2022
Q4
$126 Sell
176
-25
-12% -$22 ﹤0.01% 4860
2022
Q3
$0 Sell
201
-119
-37% -$168 ﹤0.01% 4896
2022
Q2
$1K Sell
320
-143,526
-100% -$310K ﹤0.01% 4681
2022
Q1
$463K Buy
143,846
+11,824
+9% +$39.9K ﹤0.01% 3009
2021
Q4
$568K Sell
132,022
-415,198
-76% -$2.25M ﹤0.01% 2774
2021
Q3
$3.27M Buy
547,220
+25,937
+5% +$174K ﹤0.01% 2459
2021
Q2
$4.32M Sell
521,283
-287,522
-36% -$2.33M ﹤0.01% 2374
2021
Q1
$6.95M Buy
808,805
+692
+0.1% +$7.67K ﹤0.01% 2163
2020
Q4
$9.79M Buy
808,113
+345,600
+75% +$4.77M ﹤0.01% 1977
2020
Q3
$7.52M Buy
+462,513
New +$7.58M ﹤0.01% 1928
2015
Q3
Sell
-370,500
Closed -$2.57M 2722
2015
Q2
$2.57M Buy
+370,500
New +$2.59M ﹤0.01% 2403

Other funds holding CGEN

Fidelity Investments's CGEN Position: Q2 2024 in Review

Fidelity Investments sold out of Compugen (CGEN) in Q2 2024, closing a stake of 150 shares — an estimated $387 sold.

Fidelity Investments first reported a position in CGEN in Q2 2015 and held it in 14 quarters. The position peaked at $9.79M in Q4 2020. 66 funds tracked by Wall St. Rank hold CGEN as of Q2 2024.

  • Fidelity Investments reported no remaining Compugen position as of Q2 2024 after selling out during the quarter.
  • Fidelity Investments sold 150 Compugen shares in Q2 2024, an estimated $387.
  • Fidelity Investments first reported a position in Compugen in Q2 2015 and held it in 14 quarters.
  • Fidelity Investments's Compugen position peaked at $9.79M in Q4 2020.
  • 66 funds tracked by Wall St. Rank held Compugen as of Q2 2024.

Based on Fidelity Investments's 13F filing for Q2 2024, filed 13 Aug 2024.